Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients

Rheumatology (United Kingdom)

Volumn 53, Issue 8, 2014, Pages 1504-1512

  Chiewchengchol, Direkrit ^a   Murphy, Ruth ^b   Morgan, Thomas ^a   Edwards, Steven W ^a   Leone, Valentina ^c   Friswell, Mark ^d   Pilkington, Clarissa ^e   Tullus, Kjell ^e   Rangaraj, Satyapal ^f   McDonagh, Janet E ^g   Gardner Medwin, Janet ^h   Wilkinson, Nick ⁱ   Riley, Phil ^j   Tizard, Jane ^k   Armon, Kate ^l   Sinha, Manish D ^m   Ioannou, Yiannis ⁿ   Mann, Rebecca ^o   Bailey, Kathryn ^p,q   Davidson, Joyce ^r   Baildam, Eileen M ^s   Pain, Clare E ^s   Cleary, Gavin ^s   McCann, Liza J ^s   Beresford, Michael W ^a   more..

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

^d Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^g BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

ⁱ OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^j MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^k BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^l NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^m EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^o MUSGROVE PARK HOSPITAL   (United Kingdom)

^p UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

^q GEORGE ELIOT HOSPITAL NHS TRUST   (United Kingdom)

^r ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^s ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

ACR criteria; Disease severity; Juvenile onset systemic lupus erythematosus; Major organ involvement; Mucocutaneous manifestations; PBILAG 2004 index; Skin involvement

Indexed keywords

CARBAMAZEPINE; ETANERCEPT; MINOCYCLINE; PREDNISOLONE;

ALOPECIA; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS; KIDNEY DISEASE; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UNITED KINGDOM;

ACR CRITERIA; DISEASE SEVERITY; JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS; MAJOR ORGAN INVOLVEMENT; MUCOCUTANEOUS MANIFESTATIONS; PBILAG-2004 INDEX; SKIN INVOLVEMENT;

ADOLESCENT; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEVERITY OF ILLNESS INDEX; SKIN; SKIN DISEASES;

EID: 84904858960     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu137     Document Type: Article

References (29)

1. Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol 2010;6:538-46.
2. Tucker LB, Uribe AG, Fernández M et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008;17:314-22.
3. Hiraki LT, Benseler SM, Tyrrell PN et al. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 2009;36:2539-46.
4. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003;82:299-308.
5. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 1995;22:1265-70.
6. Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am 2012;59:345-64.
7. Habibi S, Saleem MA, Ramanan AV. Juvenile systemic lupus erythematosus: review of clinical features and management. Indian Pediatr 2011;48:879-87.
8. Mina R, Brunner HI. Pediatric lupus-are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin North Am 2010;36:53-80, vii-viii.
9. Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:577-87.
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
11. Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 2009;10:365-81.
12. Parodi A, Massone C, Cacciapuoti M et al. Measuring the activity of the disease in patients with cutaneous lupus erythematosus. Br J Dermatol 2000;142:457-60.
13. Khatibi M, Shakoorpour AH, Jahromi ZM, Ahmadzadeh A. The prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus. Lupus 2012;21:1312-5.
14. Urman JD, Lowenstein MB, Abeles M, Weinstein A. Oral mucosal ulceration in systemic lupus erythematosus. Arthritis Rheum 1978;21:58-61.
15. Isenberg DA, Rahman A, Allen E et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology 2005;44:902-6.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
17. Bouaziz JD, Barete S, Le Pelletier F et al. Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases. Lupus 2007;16:163-7.
18. Callen JP, Kingman J. Cutaneous vasculitis in systemic lupus erythematosus. A poor prognostic indicator. Cutis 1983;32:433-6.
19. Marks SD, Pilkington C, Woo P, Dillon MJ. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhoodonset systemic lupus erythematosus. Rheumatology 2004;43:1186-9.
20. Watson L, Leone V, Pilkington C et al. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum 2012;64:2356-65.
21. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
22. Papadimitraki ED, Isenberg DA. Childhood-and adultonset lupus: an update of similarities and differences. Expert Rev Clin Immunol 2009;5:391-403.
23. Wenzel J, Zahn S, Tüting T. Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets. Lupus 2010;19:1020-8.
24. Lee HJ, Sinha AA. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity 2006;39:433-44.
25. Kuhn A, Krammer PH, Kolb-Bachofen V. Pathophysiology of cutaneous lupus erythematosus-novel aspects. Rheumatology 2006;45(Suppl 3): iii14-6.
26. Ciolkiewicz M, Kuryliszyn-Moskal A, Klimiuk PA. Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients. Clin Rheumatol 2010;29:175-80.
27. Riccieri V, Spadaro A, Ceccarelli F et al. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus 2005;14:521-5.
28. Richter JG, Sander O, Schneider M, Klein-Weigel P. Diagnostic algorithm for Raynaud's phenomenon and vascular skin lesions in systemic lupus erythematosus. Lupus 2010;19:1087-95.
29. Petri M, Orbai A-M, Alarcón GS et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86.